Target intelligence / Profile preview

Hemagglutinin protein of Influenza A(H3N2)

Molecular classification
Viral protein, Glycoprotein, Surface antigen
01

Overview

Hemagglutinin (HA) is a surface glycoprotein and the principal antigenic determinant of the influenza A(H3N2) virus. It mediates viral attachment to host cells and subsequent membrane fusion, enabling viral entry. HA is a homotrimeric protein, with each monomer cleaved into HA1 and HA2 subunits. The globular head domain (mainly HA1) is responsible for receptor binding and is the primary target for neutralizing antibodies. The stem domain (mainly HA2) anchors the protein to the viral membrane and contains elements critical for fusion. Antigenic drift necessitates frequent updates to influenza vaccines.

Other names
HAH3N2 Hemagglutinin
02

Mechanism of action

NA inhibitors prevent release of new virions. Fusion inhibitors prevent viral entry by blocking fusion of the viral membrane with the host cell membrane. Monoclonal antibodies neutralize the virus by binding to HA and blocking receptor binding or membrane fusion.

03

Biological functions

Receptor bindingMembrane fusionViral entryAntigen presentation
04

Disease associations

InfectionInfluenzaRespiratory disease
05

Safety considerations

Antigenic drift leading to vaccine mismatchDevelopment of resistance to antiviral drugsPotential for pandemic outbreaks due to novel HA subtypes
06

Interacting drugs

NA inhibitors (e.g., Oseltamivir, Zanamivir)

2 more in the full profile.

07

Biomarkers

HA antibody titers (for vaccine efficacy)HA sequence variations (for monitoring antigenic drift)

Beyond the preview

Go deeper on Hemagglutinin protein of Influenza A(H3N2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemagglutinin protein of Influenza A(H3N2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call